DUBLIN, Dec 9, 2016 /PRNewswire/ --
Research and Markets has announced the addition of the "Cartilage Repair/ Cartilage Regeneration Market by Treatment modalities (Chondrocyte Transplantation, Growth Factor Technology, Tissue Scaffolds, Cell-free composites), Application (Hyaline Cartilage, Fibrocartilage), Region - Forecast to 2021" report to their offering.
The global cartilage repair market is projected to reach USD 779.8 Million by 2021 from USD 414.6 Million in 2016, growing at a CAGR of 13.5% during the forecast period of 2016 to 2021.
Increase in obese population and rising incidence of sports injuries are the major factors driving the growth of this market. However, high cost of therapy and unfavorable reimbursement scenario are the major factors that are restraining the growth of the market.
The cartilage repair/ cartilage regeneration market is segmented on the basis of treatment modalities, application, and region. Based on treatment modalities, the market is segmented into cell based approaches and non-cell based approaches. Cell based approaches are further segmented into chondrocyte transplantation, growth factor technology, and stem cells. Non-cell based approaches are segmented into tissue scaffolds and cell-free composites.
The cell based approaches segment is expected to account for the largest market share in 2016.This treatment modality segment is also expected to be the fastest growing segment in the market. The large share and high growth of this segment can be attributed to long-term results of these therapies in terms of cartilage repair which makes it most preferred therapy.
On the basis of applications, the market is segmented into hyaline cartilage and fibrocartilage. Among this segments, the hyaline cartilage segment is expected to account for the largest market share in 2016. Hyaline cartilage application segment is also expected to be the fastest growing application segment in the cartilage repair/ cartilage regeneration market. The large share and high growth of this segment can be attributed to the high prevalence of cartilage damage in hyaline cartilage.
North America is expected to be the fastest-growing regional segment in the cartilage repair market. North America is also expected to account for largest share in the market, by region in 2016. The high growth and largest share of this segment can primarily be attributed to the expansion of the market in this region due to presence of major players in this market and wide availability of cartilage repair products.
The major players operating in the cartilage repair/ cartilage regeneration market include Zimmer Biomet Holdings, Inc. (U.S.), Vericel Corporation (U.S.), Smith & Nephew plc (U.K.), Osiris Therapeutics, Inc. (U.S.), and Arthrex Inc. (U.S.).
Key Topics Covered:
2 Research Methodology
3 Executive Summary
4 Cartilage Repair and Regeneration Market: Market Overview
5 Cartilage Repair and Regeneration Market, By Treatment Modalities
6 Cartilage Repair and Regeneration Market, By Application
7 Cartilage Repair and Regeneration Market, By Region
8 Cartilage Repair and Regeneration Market: Competitive Landscape
9 Cartilage Repair and Regeneration Market: Company Profiles
- Anika Therapeutics S. R. L.
- Arthrex, Inc.
- B. Braun Melsungen AG
- Conmed Linvatec
- Depuy Synthes (Johnson & Johnson Company)
- Osiris Therapeutics, Inc.
- RTI Surgical
- Smith & Nephew PLC
- Vericel Corporation
- Zimmer Biomet Holdings, Inc.
For more information about this report visit http://www.researchandmarkets.com/research/3c7wlg/cartilage_repair
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets